BJU Int July 2016 PMID 26469362

The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin.

Paolo Gontero, Richard Sylvester, Francesca Pisano, Steven Joniau, Marco Oderda, Vincenzo Serretta, Stéphane Larré, Savino Di Stasi, Bas Van Rhijn, Alfred J Witjes, Anne J Grotenhuis, Renzo Colombo, Alberto Briganti, Marek Babjuk, Viktor Soukup

Full text PDF Download social card

Mentions

Peak: 3 in Jul 2019

across 4 sources since Jul 2016

Extended reach

23,188

potential audience

Total likes

Video views

1,821

Mentions per month

Jul 2016 – Jul 2019

Where it's discussed

X / Twitter3 posts
News2 articles
Blogs2 articles
YouTube1 videos

AI synopsis

What people are saying

The posts show moderate agreement and interest by referencing the article and emphasizing its relevance to clinical decision-making for bladder cancer patients. The tone is neutral and factual, with mentions of terms like 'clinical outcomes' and 'importance,' reflecting a cautious recognition of the study's significance without extensive debate or critique.

AgreementModerate agreement

The posts generally acknowledge the significance of the study, suggesting agreement on the importance of reTUR in specific scenarios, especially when muscle is absent in initial specimens.

InterestModerate interest

Both posts show moderate interest by highlighting key aspects like clinical outcomes and methodological importance, but lack enthusiasm or deep discussion.

EngagementModerate engagement

Comments mention the article and related clinical concepts but don't delve deeply into analysis or critique, indicating a moderate level of engagement.

ImpactNeutral impact

While the publication's findings are recognized as clinically relevant, posts indicate that the discussion remains superficial without exploring broad implications or future research.

Abstract in brief

A large study of 2451 patients with T1 high-grade bladder cancer treated with BCG showed that repeat transurethral resection (reTUR) improves outcomes like recurrence, progression, cancer-specific survival, and overall survival mainly when muscle was not found in the initial TUR specimen.
When muscle was absent in the first TUR, reTUR was associated with better outcomes, but it did not provide benefits if muscle was already present, suggesting that reTUR may not be needed in such cases.
Overall, the study indicates that the presence of muscle in the initial TUR specimen can help decide whether a reTUR is beneficial for patients with this high-grade bladder cancer.

Read the full abstract

All mentions

Re-TUR's Role in Managing High-Grade T1 Bladder Cancer Treated with BCG

A large study of 2451 patients shows reTUR improves outcomes when muscle was absent in the initial TUR specimen, aiding treatment decisions for T1 high-grade bladder cancer treated with BCG.

BJUI · Jul 27, 2016 1,821 views

KCH_Urology

@Urology_KCH · X

RT @BJUIjournal: #ThrowbackThursday: The impact of re‐TUR on clinical outcomes in a large multicentre cohort of patients with T1 high‐grade…

Jul 18, 2019 · 2 shares · 1,216 followers View post →

Daniel Roberto Salas Chavez

@UroSalas · X

RT @BJUIjournal: #ThrowbackThursday: The impact of re‐TUR on clinical outcomes in a large multicentre cohort of patients with T1 high‐grade…

Jul 18, 2019 · 2 shares · 617 followers View post →

BJU International

@BJUIjournal · X

Jul 18, 2019 · 3 likes · 2 shares · 19,522 followers View post →